HDAC(组蛋白去乙酰化酶)是一类酶,可从组蛋白上的 ε-N-乙酰赖氨酸氨基酸中去除乙酰基(O=C-CH3),使组蛋白能够更紧密地包裹 DNA。这很重要,因为 DNA 包裹在组蛋白周围,而 DNA 表达受乙酰化和去乙酰化的调控。其作用与组蛋白乙酰转移酶相反。HDAC 蛋白现在也称为赖氨酸去乙酰化酶 (KDAC),以描述其功能而不是其靶标,其中还包括非组蛋白。组蛋白去乙酰化酶与乙酰多胺酰胺水解酶和乙偶姻利用蛋白一起形成了一个古老的蛋白质超家族,称为组蛋白去乙酰化酶超家族。
HDAC (Histone deacetylases) are a class of enzymes that remove acetyl groups (O=C-CH3) from an ε-N-acetyl lysine amino acid on ahistone, allowing the histones to wrap the DNA more tightly. This is important because DNA is wrapped around histones, and DNA expression is regulated by acetylation and de-acetylation. Its action is opposite to that of histone acetyltransferase. HDAC proteins are now also called lysine deacetylases (KDAC), to describe their function rather than their target, which also includes non-histone proteins. Together with the acetylpolyamine amidohydrolases and the acetoin utilization proteins, the histone deacetylases form an ancient protein superfamily known as the histone deacetylase superfamily.
Tasquinimod-d3 (ABR-215050-d3) 是 Tasquinimod (MS-D78542) 的氘代标记同位素,而 Tasquinimod 是一种口服抗血管生成剂,在抗性前列腺癌研究中发挥重要作用,其与 HDAC4 Zn2+ 结合结构域结合的 Kd 值为 10-30 nM,同时也是一种 S100A9 抑制剂。
Tasquinimod 是一种口服抗血管生成剂,有潜力用于去势抵抗性前列腺癌的研究,其与 HDAC4 Zn2+ 结合结构域结合的 Kd 值为 10-30 nM,同时也是一种 S100A9 抑制剂。
Tasquinimod (Standard) 是 Tasquinimod 的分析标准品,用于研究及分析应用;Tasquinimod 是一种口服抗血管生成剂,有潜力用于去势抵抗性前列腺癌的研究,其与 HDAC4 Zn2+ 结合结构域结合的 Kd 值为 10-30 nM,同时也是一种 S100A9 抑制剂。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号